Market Cap 98.75M
Revenue (ttm) 3.55M
Net Income (ttm) -14.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -419.15%
Debt to Equity Ratio 0.00
Volume 141,900
Avg Vol 200,358
Day's Range N/A - N/A
Shares Out 23.46M
Stochastic %K 11%
Beta 0.23
Analysts Strong Sell
Price Target $16.07

Company Profile

Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages in Phase...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 587 8170
Address:
5850 San Felipe St., Suite 500, Houston, United States
Goodstockday
Goodstockday Mar. 22 at 12:19 AM
$COYA So, does anyone recall if they said if the original 4 ALS participants went back on the drug and are being followed long term?
1 · Reply
zampy
zampy Mar. 20 at 8:19 PM
$COYA I bought more..Why? I am getting cheaper than Dr Reddy and Eihorn...I know this is huge upside..... Keep the faith.....
0 · Reply
zampy
zampy Mar. 19 at 7:40 PM
$COYA Free shares dont stop relentless...ALLELE group...Since Dec 22nd.....1202...Selling like amateurs.....I know ore ipo 6.6m 5 years ago...Sure not that # but they're thick......Relentless every day.....We have ok buying but not anywhere near what is needed. Enabled A.H.'S.
1 · Reply
irf944
irf944 Mar. 19 at 5:46 PM
$COYA Based upon Point & Figure chart, the support is $4.00. Close enough to $4 for me to add. Clinical Advancements: The update of yesterday confirmed the successful launch of the ALSTARS Phase 2 trial for ALS and recent FDA acceptance of the IND application for COYA 302 to treat frontotemporal dementia (FTD).
1 · Reply
Jwa68
Jwa68 Mar. 19 at 5:42 PM
$COYA Well this is officially absurd. If i had investable capital, I'd double my already large position here. Dr. Reddy's acquired them. $17 best guess and that will be giving it away.
1 · Reply
irf944
irf944 Mar. 19 at 5:35 PM
$COYA Added. Following Dr. Reddy. Nobody knows the sceience as well Dr. Reddy and they continue to invest in Coya. Company has no debt, plenty of cash and a partner in Dr. Reddy. Really like the risk/reward at these low prices. Historically, it doesn' take much for stock to move based upn relatively low float.
0 · Reply
Chrissytina
Chrissytina Mar. 19 at 4:32 PM
$COYA Shorts seem to always win here 😡 when’s our turn 🤦🏼‍♀️
1 · Reply
AIBioScanner
AIBioScanner Mar. 18 at 3:55 PM
$COYA AI-Based Findings on COYA After running COYA through my AI-driven quantitative framework (MACD, RSI, moving averages, volatility structure), the stock is currently in a consolidation phase following a recent decline. COYA is trading around $4.68, below both the 20-day ($4.74) and 50-day ($5.05) moving averages — indicating short-term pressure. Key signals: • RSI near 48 – neutral momentum • MACD slightly negative but stabilizing • 60-day range between $3.94 support and $6.62 resistance As shown in the chart, price recently pulled back sharply and is attempting to stabilize above the $4 area. 1-Month Outlook: Base scenario: continued consolidation between $4.00–$5.00 Breakout above $5.05 could open a move toward $5.50–$6.00 Breakdown below $3.94 may extend downside pressure At this stage, the structure remains neutral-to-weak and requires confirmation before signaling a directional shift. Not financial advice. This analysis is based on quantitative and technical modeling only.
1 · Reply
VINCE_CARTER
VINCE_CARTER Mar. 18 at 2:31 PM
0 · Reply
EmotionlessRobot
EmotionlessRobot Mar. 18 at 12:46 PM
$COYA Brilliant news today. Biomarker data in FTD showing TReg dysfunction further bolstering what we saw in terms of patient improvements in the actual trial itself.
1 · Reply
Latest News on COYA
Coya Therapeutics Announces $11.1 Million Private Placement

Jan 30, 2026, 8:00 AM EST - 7 weeks ago

Coya Therapeutics Announces $11.1 Million Private Placement


Coya Therapeutics Now Pivots Toward Phase 2 In ALS And FTD

Feb 7, 2025, 5:17 PM EST - 1 year ago

Coya Therapeutics Now Pivots Toward Phase 2 In ALS And FTD


Coya Therapeutics: Buying The Dip After Unwarranted Sell-Off

Oct 31, 2024, 10:31 AM EDT - 1 year ago

Coya Therapeutics: Buying The Dip After Unwarranted Sell-Off


Goodstockday
Goodstockday Mar. 22 at 12:19 AM
$COYA So, does anyone recall if they said if the original 4 ALS participants went back on the drug and are being followed long term?
1 · Reply
zampy
zampy Mar. 20 at 8:19 PM
$COYA I bought more..Why? I am getting cheaper than Dr Reddy and Eihorn...I know this is huge upside..... Keep the faith.....
0 · Reply
zampy
zampy Mar. 19 at 7:40 PM
$COYA Free shares dont stop relentless...ALLELE group...Since Dec 22nd.....1202...Selling like amateurs.....I know ore ipo 6.6m 5 years ago...Sure not that # but they're thick......Relentless every day.....We have ok buying but not anywhere near what is needed. Enabled A.H.'S.
1 · Reply
irf944
irf944 Mar. 19 at 5:46 PM
$COYA Based upon Point & Figure chart, the support is $4.00. Close enough to $4 for me to add. Clinical Advancements: The update of yesterday confirmed the successful launch of the ALSTARS Phase 2 trial for ALS and recent FDA acceptance of the IND application for COYA 302 to treat frontotemporal dementia (FTD).
1 · Reply
Jwa68
Jwa68 Mar. 19 at 5:42 PM
$COYA Well this is officially absurd. If i had investable capital, I'd double my already large position here. Dr. Reddy's acquired them. $17 best guess and that will be giving it away.
1 · Reply
irf944
irf944 Mar. 19 at 5:35 PM
$COYA Added. Following Dr. Reddy. Nobody knows the sceience as well Dr. Reddy and they continue to invest in Coya. Company has no debt, plenty of cash and a partner in Dr. Reddy. Really like the risk/reward at these low prices. Historically, it doesn' take much for stock to move based upn relatively low float.
0 · Reply
Chrissytina
Chrissytina Mar. 19 at 4:32 PM
$COYA Shorts seem to always win here 😡 when’s our turn 🤦🏼‍♀️
1 · Reply
AIBioScanner
AIBioScanner Mar. 18 at 3:55 PM
$COYA AI-Based Findings on COYA After running COYA through my AI-driven quantitative framework (MACD, RSI, moving averages, volatility structure), the stock is currently in a consolidation phase following a recent decline. COYA is trading around $4.68, below both the 20-day ($4.74) and 50-day ($5.05) moving averages — indicating short-term pressure. Key signals: • RSI near 48 – neutral momentum • MACD slightly negative but stabilizing • 60-day range between $3.94 support and $6.62 resistance As shown in the chart, price recently pulled back sharply and is attempting to stabilize above the $4 area. 1-Month Outlook: Base scenario: continued consolidation between $4.00–$5.00 Breakout above $5.05 could open a move toward $5.50–$6.00 Breakdown below $3.94 may extend downside pressure At this stage, the structure remains neutral-to-weak and requires confirmation before signaling a directional shift. Not financial advice. This analysis is based on quantitative and technical modeling only.
1 · Reply
VINCE_CARTER
VINCE_CARTER Mar. 18 at 2:31 PM
0 · Reply
EmotionlessRobot
EmotionlessRobot Mar. 18 at 12:46 PM
$COYA Brilliant news today. Biomarker data in FTD showing TReg dysfunction further bolstering what we saw in terms of patient improvements in the actual trial itself.
1 · Reply
kornlover
kornlover Mar. 18 at 12:45 PM
$COYA https://academic.oup.com/braincomms/advance-article/doi/10.1093/braincomms/fcag089/8524244?searchresult=1&login=false
0 · Reply
Jwa68
Jwa68 Mar. 18 at 10:39 AM
$COYA https://youtube.com/watch?v=_kyqhjmZX7w&si=Eg0ZHhdqyMHtlgvJ
0 · Reply
jwilk24
jwilk24 Mar. 17 at 8:32 PM
$COYA added in the high $4.30’s Thank you MM
0 · Reply
Robby83
Robby83 Mar. 16 at 7:06 PM
$COYA added at $4.50 as planned and will gladly pickup more if we head lower. Bullish long term, who know short term.
0 · Reply
DARKP00L
DARKP00L Mar. 16 at 1:42 PM
$COYA 09:26 on Mar. 16 2026 Coya Therapeutics Files Prospectus To Register Resale Of 2,522,727 Common Shares Issued In Private Placement #tradeideas
1 · Reply
Jwa68
Jwa68 Mar. 14 at 12:15 PM
$COYA Know what you own... https://youtu.be/A-F9veu4duM?si=wqOtUiH81LDbcsyz
1 · Reply
zampy
zampy Mar. 13 at 8:09 PM
$COYA Appeared to me dold all day long at the bid the legacy no price shares..Many times this happens they're getting rid of all. No cost basus federally exemot sold like this. The conflict in the mideast fueling the selling.... $2.75 in cash ..no debt...13g filed by Dr Reddy's bodes well for real investors. Management is a oriven entity and woll be with the guys that hang in there..
0 · Reply
jwilk24
jwilk24 Mar. 13 at 8:00 PM
$COYA added here in the low $4.50’s
1 · Reply
zampy
zampy Mar. 13 at 2:12 PM
$COYA I believe 25k offers are Legacy coming to an end. In Dec 22nd 2025 was 5 year period for pre ipo stock. It is 1202 That is now eligible for federal exemption. I believe over 2.5m has been sold in my opinion and less than 250k is left my guess.It is getting gobbled up. It will become a cleaner stock in the next 30 days..And institutions putting away.
0 · Reply
Milliondollarskill
Milliondollarskill Mar. 13 at 12:34 PM
$COYA curious why movement? Here it is: https://www.sec.gov/Archives/edgar/data/1835022/000157587226000104/xslSCHEDULE_13G_X01/primary_doc.xml
1 · Reply
Jwa68
Jwa68 Mar. 12 at 9:39 PM
$COYA Dr. Reddy's filed a 13G owning 9.7%
2 · Reply
Jwa68
Jwa68 Mar. 11 at 12:45 PM
$COYA Still half off sale.
1 · Reply